Trials / Completed
CompletedNCT05229406
Healthy Minds Program App Dosage
Healthy Minds Program (HMP) App Dosage Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- University of Wisconsin, Madison · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The study will evaluate the effectiveness of the Healthy Minds Program (HMP) meditation app on participants experiencing depression and/or anxiety. Participants will be assigned to use the HMP app 5- or 15-minutes per day for 4 weeks.
Detailed description
Depression and anxiety are highly common, but access to evidence-based treatments is limited. Meditation training delivered through mobile health (mHealth) technology may increase access to effective strategies. However, the necessary dosage of meditation practice to produce benefits is unknown. This project will investigate the feasibility, acceptability, and preliminary effectiveness of the HMP app for depression and/or anxiety and the feasibility of randomly assigning participants to practice dosages. Further, the project will provide a preliminary evaluation of the linkages between practice dosage and outcomes assessed retrospectively and in-the-moment via ecological momentary assessment (EMA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | HMP app | The HMP app is a meditation-based smartphone app designed to promote and protect psychological well-being through sustainable skills training. The program is grounded in constituents of psychological well-being identified in empirical literature. HMP provides core content, with instruction administered through a curriculum of guided practices. HMP has guided audio practices that address 4 constituents of well-being: awareness, connection, insight, and purpose. |
Timeline
- Start date
- 2022-02-21
- Primary completion
- 2022-06-27
- Completion
- 2022-06-27
- First posted
- 2022-02-08
- Last updated
- 2023-08-01
- Results posted
- 2023-08-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05229406. Inclusion in this directory is not an endorsement.